Altoida’s Vision For Alzheimer’s Care Combines Digital Screening, Blood-Based Tests, New Drugs
Earlier Detection of Cognitive Disorders with Marc Jones of Altoida
Digital Cognitive Tests: How AI Tools Could Transform Alzheimer’s Diagnosis and Care
Fierce Medtech's 2022 Fierce 15
Altoida appoints new CEO ahead of FDA submission for Alzheimer's-predicting AI
New Research of Augmented Reality-Based Cognitive Assessment of Alzheimer’s Disease Shows Promise
Altoida snags Merck KGaA-led $14M funding round for Alzheimer's diagnostic app
Exclusive: D.C. neurotech company raises $14M to help catch Alzheimer’s sooner
Neurotech Takes The Stage At JPM 2024
No Moonshots With Paper Planes: Alzheimer’s Trials Need Neurotech